Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants

Life Sciences [q-bio] Microbiology and Parasitology Bacteriology Life Sciences [q-bio] Microbiology and Parasitology Virology Life Sciences [q-bio] Microbiology and Parasitology Parasitology Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system Life Sciences [q-bio] Human health and pathology Emerging diseases Life Sciences [q-bio] Human health and pathology Infectious diseases

Isabelle COMBE : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03333752

Submitted on : Friday, September 3, 2021-11:12:24 AM

Last modification on : Friday, August 26, 2022-3:27:34 PM

Dates and versions

hal-03333752 , version 1 (03-09-2021)

Identifiers

HAL Id : hal-03333752 , version 1
DOI : 10.1016/j.jcv.2021.104868
PUBMEDCENTRAL : PMC8118707

Cite

Marielle Bedotto, Pierre-Edouard Fournier, Linda Houhamdi, Philippe Colson, Didier Raoult. Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants. Journal of Clinical Virology, 2021, 140, pp.104868. ⟨10.1016/j.jcv.2021.104868⟩. ⟨hal-03333752⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU INCIAM

12 View

0 Download